Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.75 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.48 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.48 |
| ▸ | HPGD | P15428 | 3/20 | 0.34 |
| ▸ | EGFR | P00533 | 1/20 | 0.34 |
| ▸ | SRC | P12931 | 1/20 | 0.34 |
| ▸ | MAP2K1 | Q02750 | 5/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.33 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.32 |
| ▸ | MAP2K2 | P36507 | 1/20 | 0.30 |
| ▸ | PRKCZ | Q05513 | 1/20 | 0.30 |
| ▸ | IARS2 | Q9NSE4 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12885813 | 0.96 | LMNA (0.80) | LMNACYP2C19HIF1AHPGDEGFR | |
| SCHEMBL8857302 | 0.92 | LMNA (0.74) | LMNACYP2C19HIF1AHPGDEGFR | |
| SCHEMBL29557408 | 0.92 | LMNA (0.74) | LMNACYP2C19HIF1AHPGDEGFR | |
| SCHEMBL28634498 | 0.92 | LMNA (0.74) | LMNACYP2C19HIF1AHPGDEGFR | |
| SCHEMBL12217873 | 0.91 | LMNA (0.72) | LMNACYP2C19HIF1AHPGDEGFR | |
| SCHEMBL30480271 | 0.91 | LMNA (0.72) | LMNACYP2C19HIF1AHPGDEGFR | |
| Potassium Ion SCHEMBL31229203 | 0.90 | LMNA (0.71) | LMNACYP2C19HIF1AHPGDEGFR | |
| SCHEMBL9389982 | 0.89 | LMNA (0.61) | LMNACYP2C19HIF1AHPGDEGFR | |
| SCHEMBL9188727 | 0.86 | LMNA (0.56) | LMNACYP2C19HIF1AHPGDEGFR | |
| Iopromide SCHEMBL24546 | 0.86 | LMNA (1.00) | LMNACYP2C19HIF1AHPGDEGFR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0619744-A4 | NONIONIC X-RAY CONTRAST AGENTS, COMPOSITIONS AND METHODS. | MALLINCKRODT MEDICAL INC (US) | 1995-02-08 | — | — | EP | disclosed |
| EP-0619744-A1 | NONIONIC X-RAY CONTRAST AGENTS, COMPOSITIONS AND METHODS | MALLINCKRODT MEDICAL, INC. (US) | 1994-10-19 | — | — | EP | disclosed |
| WO-1994005337-A1 | NONIONIC X-RAY CONTRAST AGENTS, COMPOSITIONS AND METHODS | MALLINCKRODT MEDICAL, INC. (US) | 1994-03-17 | — | — | WO | disclosed |
| WO-1993010825-A1 | NONIONIC X-RAY CONTRAST AGENTS, COMPOSITIONS AND METHODS | MALLINCKRODT MEDICAL, INC. (US) | 1993-06-10 | — | — | WO | disclosed |
| US-5191120-A | Process for preparing nonionic X-ray contrast agents | MALLINCKRODT MEDICAL, INC. (US) | 1993-03-02 | — | — | US | disclosed |
| EP-0504266-A1 | NONIONIC X-RAY CONTRAST AGENTS, COMPOSITIONS AND METHODS | MALLINCKRODT, INC. (US) | 1992-09-23 | — | — | EP | disclosed |
| US-5075502-A | NONIONIC X-RAY CONTRAST AGENTS, COMPOSITIONS AND METHODS | MALLINCKRODT, INC. (US) | 1991-12-24 | — | — | US | disclosed |
| WO-1991009007-A2 | NONIONIC X-RAY CONTRAST AGENTS, COMPOSITIONS AND METHODS | MALLINCKRODT, INC. (US) | 1991-06-27 | — | — | WO | disclosed |